ctDNA Monitoring for Small Cell Lung Cancer: Ready for Prime Time?

被引：5

作者：

Pellini, Bruna ^{[1
,2
]}

Chaudhuri, Aadel A. ^{[1
,3
,4
,5
,6
,7
,8
,9
,10
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA

[2] Univ S Florida, Morsani Coll Med, Dept Oncol Sci, Tampa, FL USA

[3] Washington Univ, Dept Radiat Oncol, Div Canc Biol, Sch Med, St Louis, MO USA

[4] Washington Univ, Div Biol & Biomed Sci, Sch Med, St Louis, MO USA

[5] Washington Univ, Dept Genet, Sch Med, St Louis, MO USA

[6] Washington Univ, Dept Biomed Engn, St Louis, MO USA

[7] Washington Univ, Dept Comp Sci & Engn, St Louis, MO USA

[8] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[9] Washington Univ, Sch Med, St Louis, MO USA

[10] Washington Univ, Sch Med, 4511 Forest Pk Ave, St Louis, MO 63108 USA

来源：

CLINICAL CANCER RESEARCH | 2023年 / 29卷 / 12期

关键词：

DISEASE;

D O I：

10.1158/1078-0432.CCR-23-0420

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Small cell lung cancer (SCLC) is the deadliest form of lung cancer and has few precision medicine approaches available. A recent study analyzed circulating tumor DNA (ctDNA) in 33 patients with extensive-stage SCLC and showed that ctDNA levels and response patterns correlate strongly with clinical response and survival outcomes.See related article by Sivapalan et al., p. 2310

引用

页码：2176 / 2178

页数：3

共 50 条

[21] Programmed death-ligand 1 testing in patients with non-small cell lung cancer: Ready for prime time?
Gainor, Justin F.
CANCER CYTOPATHOLOGY, 2017, 125 (08) : 591 - 593
[22] Blood-based biomarkers for lung cancer: Ready for prime time?
Vachani, Anil
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S14 - S14
[23] ALK-Targeted Therapy for Lung Cancer: Ready for Prime Time
Husain, Hatim
Rudin, Charles M.
ONCOLOGY-NEW YORK, 2011, 25 (07): : 597 - 601
[24] ctDNA/MRD Testing for Colon Cancer: A Work in Progressor Ready for Prime-Time Standard of Care?
Caughey, Bennett A.
Parikh, Aparna R.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (10):
[25] Is radiofrequency ablation treatment for small breast cancer ready for “prime time”?
Masakuni Noguchi
Breast Cancer Research and Treatment, 2007, 106 : 307 - 314
[26] Is radiofrequency ablation treatment for small breast cancer ready for "prime time"?
Noguchi, Masakuni
BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 (03) : 307 - 314
[27] Continuous EEG monitoring: is it ready for prime time?
Kurtz, Pedro
Hanafy, Khalid A.
Claassen, Jan
CURRENT OPINION IN CRITICAL CARE, 2009, 15 (02) : 99 - 109
[28] Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis
Volpe, Stefania
Piperno, Gaia
Colombo, Francesca
Biffi, Annalisa
Comi, Stefania
Mastroleo, Federico
Camarda, Anna Maria
Casbarra, Alessia
Cattani, Federica
Corrao, Giulia
de Marinis, Filippo
Spaggiari, Lorenzo
Guckenberger, Matthias
Orecchia, Roberto
Alterio, Daniela
Jereczek-Fossa, Barbara Alicja
CANCER TREATMENT REVIEWS, 2022, 110
[29] Adjuvant TKI therapy in resected EGFR-mutant non-small-cell lung cancer-ready for prime time?
Arulananda, Surein
John, Thomas
TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 1728 - 1731
[30] Small bowel motility: ready for prime time?
Soffer E.E.
Current Gastroenterology Reports, 2000, 2 (5) : 364 - 369

← 1 2 3 4 5 →